These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30168238)

  • 1. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy.
    Kimura S; Masunaga S; Harada T; Kawamura Y; Ueda S; Okuda K; Nagasawa H
    Bioorg Med Chem; 2011 Mar; 19(5):1721-8. PubMed ID: 21315608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect.
    Fithroni AB; Kobayashi K; Uji H; Ishimoto M; Akehi M; Ohtsuki T; Matsuura E
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy.
    Ahrens VM; Frank R; Boehnke S; Schütz CL; Hampel G; Iffland DS; Bings NH; Hey-Hawkins E; Beck-Sickinger AG
    ChemMedChem; 2015 Jan; 10(1):164-72. PubMed ID: 25338544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: A potential boron agent with enhanced selectivity of tumor cellular uptake.
    Quan H; Fan L; Huang Y; Xia X; He Y; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111826. PubMed ID: 33984611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
    Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
    Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
    Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
    Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
    Takeuchi I; Nomura K; Makino K
    Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron rich nanotube drug carrier system is suited for boron neutron capture therapy.
    Heide F; McDougall M; Harder-Viddal C; Roshko R; Davidson D; Wu J; Aprosoff C; Moya-Torres A; Lin F; Stetefeld J
    Sci Rep; 2021 Jul; 11(1):15520. PubMed ID: 34330984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor Targeting.
    Jyothi VGSS; Kommineni N
    Nanotheranostics; 2024; 8(4):458-472. PubMed ID: 38961887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer.
    Sumitani S; Oishi M; Yaguchi T; Murotani H; Horiguchi Y; Suzuki M; Ono K; Yanagie H; Nagasaki Y
    Biomaterials; 2012 May; 33(13):3568-77. PubMed ID: 22326646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
    Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
    Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy of cancer: current status and future prospects.
    Barth RF; Coderre JA; Vicente MG; Blue TE
    Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carborane-Containing Folic Acid
    Gruzdev DA; Telegina AA; Levit GL; Solovieva OI; Gusel'nikova TY; Razumov IA; Krasnov VP; Charushin VN
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging.
    Chen G; Yang J; Lu G; Liu PC; Chen Q; Xie Z; Wu C
    Mol Pharm; 2014 Oct; 11(10):3291-9. PubMed ID: 24521224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.